A Single-Amino-Acid Substitution in a Polymerase Protein of an H5N1 Influenza Virus Is Associated with Systemic Infection and Impaired T-Cell Activation in Mice

被引:69
|
作者
Fornek, Jamie L. [1 ]
Gillim-Ross, Laura [2 ]
Santos, Celia [2 ]
Carter, Victoria [1 ]
Ward, Jerrold M. [3 ]
Cheng, Lily I. [3 ]
Proll, Sean [1 ]
Katze, Michael G. [1 ]
Subbarao, Kanta [2 ]
机构
[1] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
[2] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
[3] NIAID, Comparat Med Branch, NIH, Rockville, MD 20852 USA
关键词
HONG-KONG; HIGH VIRULENCE; A VIRUSES; MOUSE MODEL; PATHOGENESIS; HUMANS; HOST; PATHOGENICITY; REPLICATION; PB1;
D O I
10.1128/JVI.00994-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The transmission of H5N1 influenza viruses from birds to humans poses a significant public health threat. A substitution of glutamic acid for lysine at position 627 of the PB2 protein of H5N1 viruses has been identified as a virulence determinant. We utilized the BALB/c mouse model of H5N1 infection to examine how this substitution affects virus-host interactions and leads to systemic infection. Mice infected with H5N1 viruses containing lysine at amino acid 627 in the PB2 protein exhibited an increased severity of lesions in the lung parenchyma and the spleen, increased apoptosis in the lungs, and a decrease in oxygen saturation. Gene expression profiling revealed that T-cell receptor activation was impaired at 2 days postinfection (dpi) in the lungs of mice infected with these viruses. The inflammatory response was highly activated in the lungs of mice infected with these viruses and was sustained at 4 dpi. In the spleen, immune-related processes including NK cell cytotoxicity and antigen presentation were highly activated by 2 dpi. These differences are not attributable solely to differences in viral replication in the lungs but to an inefficient immune response early in infection as well. The timing and magnitude of the immune response to highly pathogenic influenza viruses is critical in determining the outcome of infection. The disruption of these factors by a single-amino-acid substitution in a polymerase protein of an influenza virus is associated with severe disease and correlates with the spread of the virus to extrapulmonary sites.
引用
收藏
页码:11102 / 11115
页数:14
相关论文
共 50 条
  • [41] Mast cell degranulation and histamine release during A/H5N1 influenza infection in influenza-sensitized mice
    Desheva, Yulia
    Mamontov, Andrey
    Petkova, Nadezhda
    Karev, Vadim
    Nazarov, Peter
    LIFE SCIENCES, 2020, 258
  • [42] Amino Acid Substitutions Associated with Avian H5N6 Influenza A Virus Adaptation to Mice
    Zhang, Chunmao
    Zhao, Zongzheng
    Guo, Zhendong
    Zhang, Jiajie
    Li, Jiaming
    Yang, Yifei
    Lu, Shaoxia
    Wang, Zhongyi
    Zhi, Min
    Fu, Yingying
    Yang, Xiaoyu
    Liu, Lina
    Zhang, Yi
    Hua, Yuping
    Liu, Linna
    Chai, Hongliang
    Qian, Jun
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [43] Effect of single i.m. or i.v. injection of peramivir on an influenza A (H5N1) virus infection in mice
    Sidwelll, RW
    Bailey, KW
    Wong, MH
    Smee, DF
    Barnard, DL
    Bantia, S
    ANTIVIRAL RESEARCH, 2006, 70 (01) : A50 - A50
  • [44] Identification of Amino Acid Substitutions in Avian Influenza Virus (H5N1) Matrix Protein 1 by Using Nanoelectrospray MS and MS/MS
    Liu, Ning
    Song, Wenjun
    Lee, Kim-Chung
    Wang, Pui
    Chen, Honglin
    Cai, Zongwei
    JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2009, 20 (02) : 312 - 320
  • [45] Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice
    Bindumadhav M. Marathe
    Sook-San Wong
    Peter Vogel
    Fernando Garcia-Alcalde
    Robert G. Webster
    Richard J. Webby
    Isabel Najera
    Elena A. Govorkova
    Scientific Reports, 6
  • [46] Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice
    Ilyushina, Natalia A.
    Webster, Robert G.
    Govorkova, Elena A.
    ANTIVIRAL RESEARCH, 2007, 74 (03) : A31 - A32
  • [47] Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice
    Marathe, Bindumadhav M.
    Wong, Sook-San
    Vogel, Peter
    Garcia-Alcalde, Fernando
    Webster, Robert G.
    Webby, Richard J.
    Najera, Isabel
    Govorkova, Elena A.
    SCIENTIFIC REPORTS, 2016, 6
  • [48] Several amino acid substitutions alter the replication and pathogenicity of an H5N1 influenza vaccine seed virus
    Xuanxuan, N.
    Aming, Q.
    Wei, Z.
    Jiayou, Z.
    Xiaoming, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1701 - 1701
  • [49] Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice
    Ilyushina, Natalia A.
    Hay, Alan
    Yilmaz, Neziha
    Boon, Adrianus C. M.
    Webster, Robert G.
    Govorkova, Elena A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) : 3889 - 3897
  • [50] Host Genetic Variation Affects Resistance to Infection with a Highly Pathogenic H5N1 Influenza A Virus in Mice
    Boon, Adrianus C. M.
    deBeauchamp, Jennifer
    Hollmann, Anna
    Luke, Jennifer
    Kotb, Malak
    Rowe, Sarah
    Finkelstein, David
    Neale, Geoffrey
    Lu, Lu
    Williams, Robert W.
    Webby, Richard J.
    JOURNAL OF VIROLOGY, 2009, 83 (20) : 10417 - 10426